Status:
COMPLETED
Radiofrequency (RF) Ablation Prospective Outcomes Study
Lead Sponsor:
Boston Scientific Corporation
Conditions:
Pain, Chronic
Eligibility:
All Genders
Brief Summary
The objective of this study is to compile real-world outcomes of Boston Scientific commercially approved radiofrequency (RF) ablation systems in the treatment of patients diagnosed with pain
Eligibility Criteria
Inclusion
- Key
- Study candidate is scheduled to be treated with a commercially approved Boston Scientific RF system for pain per local Directions for Use (DFU)
- Signed a valid, IRB/EC/REB-approved informed consent form
- Key
Exclusion
- Meets any contraindications per locally applicable Directions for Use (DFU)
- Currently diagnosed with cognitive impairment, or exhibits any characteristic, that would limit study candidate's ability to assess pain relief or to complete study assessments
Key Trial Info
Start Date :
December 22 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 7 2025
Estimated Enrollment :
298 Patients enrolled
Trial Details
Trial ID
NCT04673032
Start Date
December 22 2020
End Date
February 7 2025
Last Update
March 13 2025
Active Locations (15)
Enter a location and click search to find clinical trials sorted by distance.
1
Elite Pain and Spine Institute
Mesa, Arizona, United States, 85203
2
Tucson Orthopaedic Institute
Tucson, Arizona, United States, 85712
3
The Spine Wellness Center in Westport
Westport, Connecticut, United States, 06880
4
Shepherd Center
Atlanta, Georgia, United States, 30309